Clara S. Lehmann
Expertise in
4
conditions

Clara S. Lehmann

Kerpener Str. 62, 
Koeln, NW, DE 
Expertise in
4
conditions
Kerpener Str. 62, 
Koeln, NW, DE 

Overview

Clara Lehmann practices practicing medicine in Koeln, Germany.

Lehmann is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, Long Haul COVID, and Disseminated Tuberculosis.

They are actively involved in clinical research, co-authoring 186 peer reviewed articles and participating in 1 clinical trial.

Locations

Kerpener Str. 62, Koeln, NW 50937, Germany
Other Locations
Robert Koch Str. 21, Koeln, NW 50931, Germany
Fürst Pückler Str. 56, Koeln, NW 50935, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Enrollment Status: Completed
Publish Date: May 30, 2024
Intervention Type: Drug
Study Drugs: Gepotidacin, Ceftriaxone, Azithromycin
Study Phase: Phase 3

186 Total Publications

Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024.
Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: May 16, 2026

Frequently Asked Questions about Clara S. Lehmann

Is Clara S. Lehmann a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Clara S. Lehmann is classified as an Advanced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Clara S. Lehmann participate in research or clinical trials?

Yes. Clara S. Lehmann has published 186 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Clara S. Lehmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lehmann's expertise for a condition
ConditionClose
      View All 29 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile